Britta Kuehlmann

Dr. Britta Kuehlmann

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BKBritta Kuehlmann
Britta Kuehlmann
CBClark A. Bonham
Clark A. Bonham
IZIsabel Zucal
Isabel Zucal
Lukas PrantlLukas Prantl
Lukas Prantl
GGGeoffrey C. Gurtner
Geoffrey C. Gurtner
Skin injury is a common occurrence and mechanical forces are known to significantly impact the biological processes of skin regeneration and wound healing. Immediately following the disruption of the skin, the process of wound healing begins, bringing together numerous cell types to collaborate in several sequential phases. These cells produce a multitude of molecules and initiate multiple signaling pathways that are associated with skin disorders and abnormal wound healing, including hypertrophic scars, keloids, and chronic wounds. Studies have shown that mechanical forces can alter the microenvironment of a healing wound, causing changes in cellular function, motility, and signaling. A better understanding of the mechanobiology of cells in the skin is essential in the development of efficacious therapeutics to reduce skin disorders, normalize abnormal wound healing, and minimize scar formation.

20 October 2018 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
PDF file
BKBritta Kuehlmann
Britta Kuehlmann
RBRebekka Burkhardt
Rebekka Burkhardt
NKNina Kosaric
Nina Kosaric
Lukas PrantlLukas Prantl
Lukas Prantl
BACKGROUND: Implant-based breast augmentation is one of the most frequently performed operations in plastic surgery worldwide, for aesthetic and reconstructive reasons. Capsular fibrosis is the most common long-term foreign body response after breast

17 January 2014 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
MWMichael Wild
Michael Wild
BKBritta Kuehlmann
Britta Kuehlmann
ASAnna Stauffenberg
Anna Stauffenberg
PJPascal Jungbluth
Pascal Jungbluth
MHMohssen Hakimi
Mohssen Hakimi
MBMarcel Betsch
Marcel Betsch

25 April 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Lukas PrantlLukas Prantl
Lukas Prantl
MGMichael Gerken
Michael Gerken
FZFlorian Zeman
Florian Zeman
MLMichael Leitzmann
Michael Leitzmann
MKMichael Koller
Michael Koller
NBNiklas Biermann
Niklas Biermann
Background: Breast-implant-associated anaplastic large cell lymphoma (BI-ALCL) and primary breast ALCL are rare extranodal manifestations of non-Hodgkin lymphoma. The rarity of both diseases, along with unreleased sales data on breast implants and constant updates of classification systems impede the calculation of an exact incidence. Methods: The database of the Tumor Center Regensburg in Bavaria was searched for patients with CD30-positive and ALK-negative anaplastic large cell lymphoma between 2002 and 2018. These lymphomas were identified by the ICD-O-3 morphology code “97023” and were cross-checked by searching the diagnosis by name the and ICD-10 code C84.7. Furthermore, we tried to calculate the incidence rates and corresponding 95% confidence intervals, standardized to 1,000,000 implant years of breast-implant-associated anaplastic large cell lymphoma and primary breast anaplastic large cell lymphoma. Results: Twelve ALK-negative and CD30-positive anaplastic large cell lymphomas were identified out of 170,405 malignancies. No case was found within the breast tissue and none of the patients had a previous history of breast implant placement. In five cases, lymph node involvement in close proximity to the breast was observed. Conclusion: We found a low incidence of anaplastic large cell lymphoma and no association to breast implants in these patients. A review of the current literature revealed inconsistent use of classification systems for anaplastic large cell lymphomas and potential overestimation of cases.

Verified
Journal Article
Open access
PDF file
BKBritta Kuehlmann
Britta Kuehlmann
FVFlorian Vogl
Florian Vogl
TKTomas Kempny
Tomas Kempny
GDGabriel Djedovic
Gabriel Djedovic
GHGeorg M. Huemer
Georg M. Huemer
LLLorenz Larcher
Lorenz Larcher
Breast cancer is among the most commonly diagnosed cancers in the world, affecting one in eight women in their lifetimes. The disease places a substantial burden on healthcare systems in developed countries and often requires surgical correction. In spite of this, much of the breast cancer pathophysiology remains unknown, allowing for the cancer to develop to later stages prior to detection. Many women undergo reduction mammaplasties (RM) to adjust breast size, with over 500,000 operations being performed annually. Tissue samples from such procedures have drawn interest recently, with studies attempting to garner a better understanding of breast cancer’s development. A number of samples have revealed nascent cancer developments that were previously undetected and unexpected. Investigating these so-called “occult” findings of cancer in otherwise healthy patients may provide further insight regarding risk factors and countermeasures. Here, we detail occult findings of cancer in reduction mammaplasty samples provided from a cohort of over 5000 patients from 16 different institutions in Europe. Although the majority of our resected breast tissue specimens were benign, our findings indicate that there is a continued need for histopathological examination. As a result, our study suggests that preoperative imaging should be routinely performed in patients scheduled for RM, especially those with risk factors of breast cancer, to identify and enable a primary oncologic approach.

3 May 2021 in BMC Molecular and Cell Biology
Verified
Journal Article
Open access
PDF file
BKBritta Kuehlmann
Britta Kuehlmann
IZIsabel Zucal
Isabel Zucal
CBClark Andrew Bonham
Clark Andrew Bonham
LJLydia-Marie Joubert
Lydia-Marie Joubert
Lukas PrantlLukas Prantl
Lukas Prantl
Background: Capsular fibrosis (CF) is the most common long-term complication in implant-based breast augmentation. It is well accepted that the foreign body response (FBR) instigates the development of fibrotic disease. Our study aims to compare murine and human samples of CF and describe the cellular and extracellular matrix (ECM) composition using scanning and transmission electron microscopy (SEM and TEM). Results: Miniature microtextured silicone breast implants were implanted in mice and subsequently harvested at days 15, 30, and 90 post-operation. Isolated human capsules with the most aggravated form of CF (Baker IV) were harvested post-operation. Both were analyzed with SEM and TEM to assess cellular infiltration and ECM structure. An architectural shift of collagen fiber arrangement from unidirectional to multidirectional was observed at day 90 when compared to days 15 and 30. Fibrosis was observed with an increase of histiocytic infiltration. Moreover, bacterial accumulation was seen around silicone fragments. These findings were common in both murine and human capsules. Conclusions: This murine model accurately recapitulates CF found in humans and can be utilized for future research on cellular invasion in capsular fibrosis. This descriptive study helps to gain a better understanding of cellular mechanisms involved in the FBR. Increases of ECM and cellularity were observed over time with SEM and TEM analysis.